Consultant in Metabolic Medicine & Honorary Research Fellow
Shivani is a Consultant in Metabolic Medicine at Imperial College Healthcare NHS Trust and an Honorary Research Fellow within Imperial College. She is an NIHR Clinical Champion in Diabetes Stratified Medicine and has been awarded a Future Leader Mentorship from the European Federation for the Study of Diabetes (2017).
She leads the MY DIABETES study, which recruits at over 40 sites around England and phenotypes young-onset diabetes in different ethnic groups. Her core research interest focuses on stratifying young-onset diabetes using biomarkers and genetics to improve treatment and identification of young-onset diabetes types.
Her other research interests include the detection of monogenic diabetes (MODY), ketosis-prone type 2 diabetes, the use and development of diabetes related biomarkers and laboratory testing guidelines.
Shivani was an NIHR Academic Clinical Fellow in metabolic medicine & chemical pathology and completed a PhD in the Section of Diabetes, Endocrinology & Metabolism, funded by a Sutherland-Earl Clinical Research Fellowship from the Diabetes Research and Wellness Foundation. She has trained in diabetes, clinical biochemistry and laboratory medicine and is a Fellow of the Royal College of Pathologists and Member of the Royal College of Physicians.
Shivani actively participants in undergraduate and postgraduate teaching programmes at Imperial College including supervision of BSc and MRes projects.
et al., 2018, Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment, Diabetic Medicine, Vol:35, ISSN:0742-3071, Pages:1291-1296
et al., 2018, Continuous Glucose Monitoring at High AltitudeEffects on Glucose Homeostasis, Medicine and Science in Sports and Exercise, Vol:50, ISSN:0195-9131, Pages:1679-1686
et al., 2018, Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort, Bmj Open, Vol:8, ISSN:2044-6055
Misra S, 2017, Pancreatic autoantibodies: who to test and how to interpret the results, Practical Diabetes, Vol:34, ISSN:2047-2897
et al., 2017, Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study, Bmj Open, Vol:7, ISSN:2044-6055